Atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers

High mortality among hospital-acquired COVID-19 infection in patients with cancer: an observational cohort study

Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC

A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma